Laverock Therapeutics

Developing the next generation of programmable #cell #therapies. With dedicted labs in the UK, Laverock Therapeutics has an experienced and knowledgeable team.

[Laverock Therapeutics @LaverockTx]

Combining #GeneEditing and RNAi can enhance #AdvancedTherapies. Read our recent article for BioInsights where Vlad Seitan, CSO, discusses GEiGS technology and its advantages in iPSC-derived allogeneic cell therapy. @CGT_Insights https://t.co/t8Qu12m6A3

[Laverock Therapeutics @LaverockTx]

We’re pleased to announce £1m funding via the @InnovateUK Investor Partnerships Future Economy programme with support from @UKI2S to progress our immune effector cell therapeutic programme aiming to combat hard-to-treat cancers.

https://t.co/8Vw3jYSwkd @UKRI_News

[Laverock Therapeutics @LaverockTx]

We’re at #ESGCT2023 this week discussing how GEiGS technology enables the development of products with improved efficacy, safety and accessibility. Interested in partnering?
Meet us at one of our posters P516, P582 and P706.
https://t.co/1sn4pjHkXR @ESGCT

[Laverock Therapeutics @LaverockTx]

Will you be at #ESGCT2023 next week?
We’ll be presenting a series of posters looking at the therapeutic applications of our #GeneEditing technology, get in touch to arrange a meeting at the conference. https://t.co/1sn4pjHkXR @ESGCT

[Laverock Therapeutics @LaverockTx]

What a great first day at #CGMesa23, looking forward to many more engaging discussions over the next two days.
Don’t miss our company presentation at 11am on 12th October. @alliancerm https://t.co/zij6Vl7iG0 #CellTherapy #GeneTherapy

[Life Science Integrates @LSIntegrates]

Will the #ATMP sector see a return to previous levels of funding?
Join the debate with experts from @CGTCatapult
@ComplementTx, Bone Therapeutics @EliLillyandCo @pdc_line @ParkwalkAdvisor & Laverock at #AdvancedTherapiesIntegrates, sponsored by @SteBioCat
https://t.co/trl8GiF5Xj

[Laverock Therapeutics @LaverockTx]

We’re looking forward to connecting with senior executives and top stakeholders to discuss the latest progress in #CellandGeneTherapies @alliancerm’s #CGMesa23!
Our CEO will be presenting at 11am on 12th October - See you in California!

https://t.co/zij6Vl7iG0

[Sciad Newswire @sciadnewswire]

Today @LaverockTx, established in 2021 to commercialise the gene editing induced gene silencing (GEiGS®) platform for all human therapeutic applications, is pleased to announce that it has expanded its seed funding round to £13.5M.

https://t.co/aAZOwRZFmD

[Laverock Therapeutics @LaverockTx]

We’re pleased to announce that we’ve raised £13.5M to continue development of GEiGS technology and progress our programmes in #RegenerativeMedicine and #ImmunoOncology. https://t.co/wV35bEW8If

[Laverock Therapeutics @LaverockTx]

Fantastic week at #ASGCT23 connecting with some real drivers of #CellTherapy & #GeneTherapy development. If you missed us, please get in touch to find out more about Laverock and GEiGS. https://t.co/gwvyFJJkJD

[Laverock Therapeutics @LaverockTx]

It was great to see so many people at our #ASGCT23 poster yesterday and to share our new data on the stability, tunability and programmability attributes of GEiGS gene silencing. Stop by poster 759 if you missed it! https://t.co/UWN3eY2dmO

[Laverock Therapeutics @LaverockTx]

Tom Payne and Vlad Seitan are at #ASGCT23 to meet with opinion leaders & scientific researchers, to talk about LaverockTx's mission: using our Gene Editing induced Gene Silencing (GEiGS) platform to engineer widely available next gen. #celltherapies, with positive health outcomes

[Laverock Therapeutics @LaverockTx]

Founded to develop next gen programmable #celltherapies, Laverock has a growing team of scientific innovators & business leaders driving exciting advances in cell & gene therapies. This week we're at #ASGCT23 to talk about our technology & partnering opportunities. See you there!

[UMass Chan Medical School @UMassChan]

Terence R. Flotte, MD, newly elected vice president of @ASGCTherapy, describes his leadership approach at @UMassChan and discusses his work investigating the use of #genetherapy for genetic diseases in kids on the “Giants of Gene Therapy” #podcast: https://t.co/hqUwotmqmo @HPKiem

[ASGCT @ASGCTherapy]

We can't wait to see you TOMORROW for the start of #ASGCT23! Already registered? Here's what you should know before you go: https://t.co/IK8MoofwVW

Not yet registered? Attend in person in Los Angeles or watch virtually from anywhere! #genetherapy #celltherapy

[Laverock Therapeutics @LaverockTx]

On the way to LA for #ASGCT23 and looking forward to seeing old friends & making new ones.

We're delighted to be presenting our gene editing induced gene silencing (GEiGS) platform & to share a key update ahead of our session on Wednesday https://t.co/1ksRMr0xe1

[ASGCT @ASGCTherapy]

ASGCT met with @RepBarragan’s staff on the #CGT pipeline, with a special focus on #CART and other treatments for cancer. Thank you for your attention to these transformative therapies!

#ASGCTadvocacy